…
…
ROE = tax × interest × margin × turnover × leverage
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Tax burden | 0.91x | 0.51x | 0.57x | 0.62x | 0.60x |
| Interest burdendriver | 0.18x | 0.90x | 0.79x | 0.89x | 0.95x |
| Operating margin | 28.5% | 41.3% | 22.3% | 27.2% | 24.0% |
| Asset turnover | 0.37x | 0.88x | 0.50x | 0.43x | 0.46x |
| Leverage (equity mult.) | 2.69x | 1.58x | 1.40x | 1.25x | 1.11x |
| = Return on Equity (consolidated) | 4.6% | 26.4% | 7.0% | 8.2% | 6.9% |
| Return on Invested Capital (ROIC) | 11.3% | 23.9% | 7.8% | 9.2% | 7.2% |
Consolidated (pre-minority-interest) basis; the headline ROE in the ratio grid is owners’ basis.
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Current Ratio(Current Assets / Current Liabilities) | 1.62x | 2.24x | 1.44x | 2.36x | 10.55x |
| Quick Ratio((Current Assets − Inventory) / Current Liabilities) | 1.08x | 1.93x | 1.22x | 2.01x | 8.49x |
| Cash Ratio(Cash / Current Liabilities) | 0.83x | 1.21x | 0.79x | 1.70x | 6.50x |
| Working Capital(Current Assets − Current Liabilities) | $ 60 M | $ 151 M | $ 54 M | $ 126 M | $ 185 M |
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Debt to Equity (DER)(Total Debt / Total Equity) | 1.57x | 0.51x | 0.32x | 0.17x | 0.00x |
| Liabilities to Equity(Total Liabilities / Total Equity) | 1.69x | 0.58x | 0.40x | 0.25x | 0.11x |
| Debt to Assets(Total Debt / Total Assets) | 0.59x | 0.32x | 0.23x | 0.13x | 0.00x |
| Net Debt(Total Debt − Cash) | $ 393 M | $ 122 M | $ 63 M | -$ 65 M | -$ 126 M |
| Interest Coverage(EBIT / Interest Expense) | 1.22x | 9.77x | 4.71x | 8.78x | 21.69x |
| Equity Multiplier (Assets ÷ Equity) | 2.69x | 1.58x | 1.40x | 1.25x | 1.11x |
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Gross Margin(Gross Profit / Revenue) | 36.3% | 46.6% | 29.9% | 35.8% | 33.5% |
| Operating Margin(EBIT / Revenue) | 28.5% | 41.3% | 22.3% | 27.2% | 24.0% |
| Net Margin(Net Income / Revenue) | 4.6% | 19.0% | 10.0% | 15.0% | 13.7% |
| EBITDA(EBIT + D&A) | $ 134 M | $ 349 M | $ 124 M | $ 128 M | $ 117 M |
| EBITDA Margin(EBITDA / Revenue) | 44.0% | 47.7% | 35.9% | 42.6% | 39.8% |
| Return on Assets (ROA)(Net Income / Total Assets) | 1.7% | 16.7% | 5.0% | 6.5% | 6.2% |
| Return on Equity (ROE)(Net Income (Owners) / Equity (Owners)) | 6.5% | 39.4% | 9.1% | 10.8% | 9.0% |
| Tax Burden (Net ÷ Pretax) | 0.91x | 0.51x | 0.57x | 0.62x | 0.60x |
| Interest Burden (Pretax ÷ EBIT) | 0.18x | 0.90x | 0.79x | 0.89x | 0.95x |
| Return on Invested Capital (ROIC) | 11.3% | 23.9% | 7.8% | 9.2% | 7.2% |
| Turnover | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Asset Turnover(Revenue / Total Assets) | 0.37x | 0.88x | 0.50x | 0.43x | 0.46x |
| Inventory Turnover(COGS / Inventory) | 3.70x | 10.52x | 9.02x | 5.93x | 4.94x |
| Receivables Turnover(Revenue / Receivables) | 15.27x | 11.83x | 9.18x | 13.99x | 9.52x |
| Payables Turnover(COGS / Payables) | 7.97x | 16.71x | 20.25x | 19.36x | 17.21x |
| Conversion Period | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Days Inventory Outstanding (DIO)(365 × Inventory / COGS) | 98.6 days | 34.7 days | 40.5 days | 61.6 days | 73.9 days |
| Days Sales Outstanding (DSO)(365 × Receivables / Revenue) | 23.9 days | 30.8 days | 39.8 days | 26.1 days | 38.3 days |
| Days Payable Outstanding (DPO)(365 × Payables / COGS) | 45.8 days | 21.8 days | 18.0 days | 18.9 days | 21.2 days |
| Cash Conversion Cycle (CCC)(DIO + DSO − DPO) | 76.7 days | 43.7 days | 62.2 days | 68.8 days | 91.0 days |
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Free Cash Flow(Operating Cash Flow − Capex) | $ 90 M | $ 317 M | $ 149 M | $ 138 M | $ 100 M |
Price Rp 640 · market cap Rp 11 T ($ 611 M at the cited rate; statements are filed in USD)
| Multiple | ESSA | Peer median | vs median |
|---|---|---|---|
| P/E | 15.16x | 15.16x | 0% |
| P/B | 1.37x | 2.77x | -51% |
| P/S | 2.07x | 1.47x | +40% |
| EV/EBITDA | 5.30x | 127.69x(2/3) | -96% |
| EV/EBIT | 8.79x | 8.79x(1/3) | 0% |
| EV/Sales | 2.11x | 2.11x | 0% |
| FCF Yield | 16.38% | -3.74% | -539% |
| Dividend Yield | 1.56% | 0.26% | +493% |
Only 3 peers are covered here, so the median is itself one of the members. A 0% gap can simply mean ESSA sits at the median.
EV = mkt cap $ 611 M + debt $ 179 K − cash $ 126 M + minority interest $ 137 M = $ 622 M
At today’s price, the market is paying for -6.9%/yr FCF growth (-9.8% at 9.3% to -4.2% at 13.3% discount rates). Delivered over the last 4 years: 2.6% FCF · -0.7% revenue.
Reverse DCF: single-stage FCF, terminal growth 2.5%, discount band 9.3–13.3% (β=1; build cited in Methodology). Not a forecast.
This model projects the operating cash the whole business generates, discounts it back at the blended cost of capital, and subtracts net debt. What remains is the equity value, stated per share. Every input below comes from the company's own audited record or from cited market data, and you can adjust each one yourself.
Cyclical normalization: Commodity/cyclical name: the trailing years are a sample drawn from the price cycle, not a trend. Defaults are therefore normalized, using the full-window mean margin with no cycle-position growth extrapolation. That normalized margin is itself the embedded commodity-price assumption.
| Assumption | Value | Basis |
|---|---|---|
| Rf (risk-free) | 4.66% | US 10Y Treasury, 10 Jul 2026 |
| ERP (Rm − Rf) | 6.69% | Damodaran Indonesia, Jul 2026 (Baa2, CRP 2.46%) |
| β | 0.58 → 0.58 | Chemical (Basic) (unlevered) relevered at own D/E 0.00 |
| Cost of equity | 8.54% | Rf + β × ERP |
| Cost of debt | 20.00% | FY2025 interest expense ÷ total debt (clamped to a 3–20% sane band) |
| Tax rate | 35.0% | median effective rate FY2021–FY2025 computed to 40.3%, CLAMPED to 35%: above that ceiling the pretax approximation is carrying minority interests, which are already deducted separately from enterprise value, rather than tax |
| WACC | 8.54% | 100% E × CoE + 0% D × Kd × (1 − t) |
| Revenue growth (yr 1, fading) | 2.5% | terminal growth from year 1, cyclical normalization: the delivered 4-yr CAGR (-0.7%) reflects cycle position, not a trend |
| EBIT margin | 28.7% | full-cycle mean EBIT margin, FY2021–FY2025 (cyclical normalization: this margin is the embedded commodity-price assumption) |
| D&A / revenue | 14.9% | mean D&A/revenue, last 3 FYs |
| Capex / revenue | 1.3% | mean capex/revenue, last 3 FYs, for the explicit years; in the terminal year capex falls to replacement level (equal to depreciation, 14.9% of revenue) because holding a build-phase or pause-phase ratio in perpetuity misprices the company in whichever direction that phase points |
| ΔNWC / Δrevenue | 6.2% | median ΔNWC/Δrevenue across the seeded years (NWC = AR + inventory − AP) |
| Terminal growth | 2.5% | BI inflation-target midpoint (2.5% ± 1%) |
| Year | +1 | +2 | +3 | +4 | +5 | T∞ |
|---|---|---|---|---|---|---|
| Growth | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% |
| Revenue | $ 302 M | $ 310 M | $ 318 M | $ 326 M | $ 334 M | $ 342 M |
| EBIT | $ 87 M | $ 89 M | $ 91 M | $ 93 M | $ 96 M | $ 98 M |
| NOPAT | $ 56 M | $ 58 M | $ 59 M | $ 61 M | $ 62 M | $ 64 M |
| + D&A | $ 45 M | $ 46 M | $ 47 M | $ 49 M | $ 50 M | $ 51 M |
| − Capex | $ 3.8 M | $ 3.9 M | $ 4.0 M | $ 4.1 M | $ 4.2 M | $ 51 M |
| − ΔNWC | $ 459 K | $ 470 K | $ 482 K | $ 494 K | $ 507 K | $ 519 K |
| FCFF | $ 97 M | $ 100 M | $ 102 M | $ 105 M | $ 107 M | $ 63 M |
| PV | $ 90 M | $ 85 M | $ 80 M | $ 75 M | $ 71 M | $ 694 M |
Check it yourself: revenue × margin = EBIT · NOPAT = EBIT × (1 − tax) · FCFF = NOPAT + D&A − Capex − ΔNWC · PV = FCFF ÷ (1+WACC)^yr · TV = FCFF(T∞) ÷ (WACC − g), discounted from year 5
EV = PV(explicit) $ 401 M + PV(TV) $ 694 M = $ 1.1 B · TV 63% of EV · − net debt -$ 126 M − minority $ 137 M
Model output: Rp 1,135/share (+77% vs price Rp 640)· exit-multiple check (127.7x): Rp 13,329
Under these assumptions the model lands 77% above today's price. The market, in other words, is paying for slower growth, a thinner margin, or a higher discount rate than the inputs here assume.
| g \ WACC | 7.5% | 8.5% | 9.5% |
|---|---|---|---|
| 2.0% | 1,236 | 1,068 | 943 |
| 2.5% | 1,332 | 1,135 | 993 |
| 3.0% | 1,451 | 1,215 | 1,050 |
Model output under the stated assumptions. Every input above comes from the company's own audited record or from cited market data, and every one can be adjusted. This is not a price target and not advice.
Educational analysis. Multiples pair today’s price with the latest audited fiscal year (trailing-FY convention); peer figures are the covered peer sample, not the whole market. Never a price target.
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $ 303 M | $ 731 M | $ 345 M | $ 301 M | $ 295 M |
| Cost of Goods Sold | $ 193 M | $ 390 M | $ 242 M | $ 193 M | $ 196 M |
| Gross Profit | $ 110 M | $ 341 M | $ 103 M | $ 108 M | $ 99 M |
| Operating Income (EBIT) | $ 86 M | $ 302 M | $ 77 M | $ 82 M | $ 71 M |
| Interest Expense | $ 71 M | $ 31 M | $ 16 M | $ 9.3 M | $ 3.3 M |
| Net Income | $ 14 M | $ 139 M | $ 35 M | $ 45 M | $ 40 M |
| Net Income Attributable to Owners | $ 14 M | $ 139 M | $ 35 M | $ 45 M | $ 40 M |
| Depreciation & Amortization | $ 47 M | $ 47 M | $ 47 M | $ 46 M | $ 47 M |
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $ 81 M | $ 148 M | $ 98 M | $ 157 M | $ 126 M |
| Accounts Receivable | $ 20 M | $ 62 M | $ 38 M | $ 22 M | $ 31 M |
| Inventory | $ 52 M | $ 37 M | $ 27 M | $ 33 M | $ 40 M |
| Current Assets | $ 158 M | $ 273 M | $ 179 M | $ 219 M | $ 204 M |
| Total Assets | $ 809 M | $ 831 M | $ 695 M | $ 694 M | $ 647 M |
| Accounts Payable | $ 24 M | $ 23 M | $ 12 M | $ 10.0 M | $ 11 M |
| Current Liabilities | $ 98 M | $ 122 M | $ 125 M | $ 93 M | $ 19 M |
| Total Liabilities | $ 509 M | $ 306 M | $ 198 M | $ 140 M | $ 63 M |
| Total Interest-Bearing Debt | $ 474 M | $ 270 M | $ 161 M | $ 93 M | $ 179 K |
| Total Equity | $ 301 M | $ 525 M | $ 498 M | $ 554 M | $ 584 M |
| Equity Attributable to Owners | $ 213 M | $ 352 M | $ 379 M | $ 417 M | $ 447 M |
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Operating Cash Flow | $ 92 M | $ 319 M | $ 151 M | $ 143 M | $ 104 M |
| Capital Expenditure | $ 1.8 M | $ 1.4 M | $ 2.7 M | $ 5.0 M | $ 3.9 M |
ESSA (formerly Surya Esa Perkasa) is a small LPG-refining and ammonia-production business near Palembang, with zero ownership or operational link to TPIA/BRPT; it is grouped in this industry purely on business-model grounds. Where TPIA and BRPT's FY2025 headline profitability was an acquisition-accounting event, ESSA's is genuinely operational: FY2025 revenue was $295.0M (matching independently-reported figures almost to the dollar), gross margin 33.47%, operating margin 23.99%, net margin 13.66%; solid, unspectacular, and consistent with a business riding down from its 2022 peak (46.64% gross margin, 39.40% ROE) as global ammonia prices normalized. The real story is balance-sheet quality: debt-to-equity fell from 1.57x (FY2021) to 0.0003x (FY2025), essentially debt-free, with interest coverage rising from 1.22x to 21.69x and net debt flipping to net cash in FY2024. Free cash flow was positive in all five years shown, unlike TPIA and BRPT. ESSA is the cleanest, most self-funding name in this industry, and its 2022 peak margins are a real reference point for how strong (and how cyclical) ammonia pricing can get, not a baseline to extrapolate forward.
ESSA depends on domestic natural gas supply and pricing for its feedstock: a smaller, more regionally-concentrated exposure than TPIA/BRPT's global-naphtha-import dependence.
Implication → Feedstock-cost risk is real but has historically been more manageable for ESSA than for TPIA: reflected in ESSA's consistently positive gross margins across all five years shown, unlike TPIA.
Ammonia is a globally-traded, fungible commodity, buyers can source elsewhere at world prices, while LPG has more locally-anchored domestic demand.
Implication → ESSA's ammonia pricing tracks the global cycle almost directly (visible in the 2022 price-spike margin jump), limiting any sustained pricing premium.
Gas-processing and ammonia-synthesis plants require significant capital and secured gas-supply agreements: meaningful barriers for a market ESSA's size, and this narrative found no evidence of a comparably-scaled new domestic entrant targeting ESSA's specific niche.
Implication → Lower near-term competitive-entry risk than TPIA faces, consistent with ESSA's steadier (if smaller-scale) margin history.
Green/blue ammonia production pathways are an emerging long-run alternative to conventional gas-based ammonia globally; LPG faces gradual substitution from grid electricity/gas-network expansion in some use cases.
Implication → A multi-decade structural question, not a near-term margin driver: ESSA's current profitability is not yet threatened by this force.
ESSA competes in the global ammonia market alongside far larger producers, but at a smaller scale with a more specialized LPG/ammonia niche than TPIA's broad olefins/polyolefins competition.
Implication → Rivalry compresses ESSA's margins during global price downturns (FY2023's 29.89% gross margin vs FY2022's 46.64%) but has not pushed them negative in any of the five years shown, unlike TPIA.
Curated narrative (educational interpretation), backed by the linked sources. The figures above are deterministic. Not investment advice.
Dominated by one integrated group (Chandra Asri + parent Barito Pacific) plus one unrelated ammonia/LPG processor: a sector still posting negative operating margins on a like-for-like basis even as 2025 headline profit was lifted by a one-time acquisition gain, not a margin recovery.